Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SCANDINAVIAN BIOPHARMA HOLDING AB
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-09-25 to 2024-09-25
Current total value of award: $17866466.78
Description: ENTEROTOXIGENIC E. COLI VACCINE DEVELOPMENT.